Novelli et al., studied CD80 expression in both patients with MCD (n = 15) and FSGS (n = 16) compared with healthy controls and in mice with adriamycin-induced nephropathy, and found no upregulation of B7-1 expression in podocytes in humans or in their animal models (31). This evidence concerns the gene CD80 and focal segmental glomerulosclerosis.